Imagine a world where participating in clinical research is as simple and unobtrusive as a routine check-up. Decentralized Clinical Trials (DCTs) have the potential to do that if they put the patient at the center when planning their trials. In this blog, we’ll unravel how DCTs are not just a …
About The clinical research industry is perpetually evolving, refining processes for optimal outcomes. While traditional feasibility has centered on site and country selection, a pivotal aspect remained overlooked – the patient. Patient Feasibility bridges this gap, offering a holistic approach that combines technology and human experience for comprehensive clinical trial …
The New Generation of Clinical Trials: Powered by Patient Feasibility and AI Read More »
*NB: The images below are clickable for a full size view. In the clinical research industry, AI like ChatGPT and Bard, built on large language models (LLMs), have emerged as tools, used to derive information with efficiency. Yet, data accuracy is not their strongest suit. LLMs have the potential to empower …
ChatGPT’s Limitations in Clinical Research: A Call for Advanced AI Read More »
Indication benchmarking in feasibility usually means knowing how long similar trials took to complete, how many patients they recruited and how many sites they opened. This data is so important for feasibility experts, yet so hard to get. I’ll tell you what we did at TrialHub in order to illustrate …
How Indication Benchmarks Make Clinical Trial Feasibility More Efficient Read More »
The clinical research landscape is on the brink of an exhilarating transformation. As we stand at this technological juncture, we proudly introduce TrialHub – not just a tool, but a process that promises to redefine the way we understand clinical trial feasibility. Unlock Fast and Accurate Insights: The need for …
Introducing: The 360-degree Knowledge Hub for Clinical Research Read More »
The clinical research industry has been on an evolutionary journey, continually adapting and refining processes to optimize results. Central to these endeavors has been country and site feasibility—key factors in determining the odds of success of a clinical trial. However, despite the comprehensive nature of these feasibility assessments, one critical …
Patient Feasibility: The Game Changer For Your Clinical Trial Planning Read More »
Underrepresentation in clinical trials presents not just an ethical but also a medical issue. Yet, diverse patient populations can be hard to reach without the data needed to locate them, understand their unmet needs and remove the barriers to participation. TrialHub represents a new way of conducting feasibility, one that …
TrialHub Empowers EmVenio to Identify New Trial Sites and Expand Access to Research Read More »
When planning a clinical trial, selecting the right location is just as crucial as timing your drug’s release. We’ve observed over the years that more than traditional feasibility alone is needed to secure a successful trial. So, what’s the essential component we’re overlooking? Tick-Tock, Watch the Clock: Time is of …
The 3 Reasons Why Traditional Feasibility is Not Enough When Planning Clinical Trials Read More »
In the landscape of clinical research, patient inclusion has become a significant matter of focus. Contract Research Organizations (CROs) must prioritize collaboration with other stakeholders to improve clinical trials’ quality and effectiveness. Through partnering with FindMeCure, Bionical Emas further supports patient inclusion in clinical research by donating a scholarship to …
Enhancing Patient Inclusion Through Partnership: Bionical Emas Joins FindMeCure & EUPATI Read More »
MCRA, a global clinical research organization (CRO) and full-service medical device diagnostics & consulting advisory firm, and FindMeCure Ltd, a health-tech company from the UK, have initiated a strategic partnership. By embedding TrialHub–FindMeCure’s data intelligence platform–into their feasibility process, MCRA aims to amplify their ability to facilitate clinical research. In …
MCRA Leverages TrialHub for Success in Clinical Trial Planning Read More »
Indegene Inc., FindMeCure, and European Patients’ Academy on Therapeutic Innovation, EUPATI, joined hands to drive advancement and innovation in treatment practices through greater patient engagement in clinical research. By working with FindMeCure’s feasibility data intelligence platform, Indegene aims to further the cause of delivering affordable patient-centric care. In line with …
We help CROs and sponsors to stop fixing patient recruitment challenges and start preventing them.
